New Drug Checklist: Enablex
Enablex (Pfizer Inc.) treats conditions that cause loss of bladder control, such as overactive bladder, urinary incontinence, urgency, and frequency.
ENABLEX (by mouth) (Novartis) treats conditions that cause loss of bladder control, such as overactive bladder, urinary incontinence, urgency, and frequency.
HOW TO USE THIS MEDICINE Extended-release tablet:
HOW TO STORE AND DISPOSE OF THIS MEDICINE
DRUGS AND FOODS TO AVOID
WARNINGS
POSSIBLE SIDE EFFECTS Call your doctor right away if you notice any of these side effects:
Tell your doctor if you notice any of these less serious side effects:
IF YOU NOTICE OTHER SIDE EFFECTS THAT YOU THINK ARE CAUSED BY THIS MEDICINE, TELL YOUR DOCTOR.
The preceding information has been made available courtesy of the UltiMedexTM Integration Services division of Micromedex, Inc. In addition to providing an extensive set of drug information and disease management leaflets for integration into clinical practice management systems, UltiMedex offers patient-specific dosing, medication advisory screening (DUR), and access to world-renowned drug and acute care knowledge bases. To learn more about how this information can be directly integrated into your system, please contact your system vendor or call Micromedex at (800) 525-9083.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
